CXS chemgenex pharmaceuticals ltd

omapro addressable market size, page-5

  1. 118 Posts.
    AU$18m was for the European rights, as an ordinary shareholder buying CXS at 69c you are paying $195m + options dilution (>10x as much) for the US rights plus a potential 10-15% royalty on European sales...as a rule of thumb Europe is about 50% size of the US market.

    IMO the numbers still do stack up and it will be interesting to see if RBS Morgans etc...revisit their sales projections.

    Rgds

    Prof
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.